Latest News
Labcorp Receives Emergency Use Authorization for First Non-Prescription At-Home Collection Kit for Combined COVID-19, Flu and RSV Detection
19 May 2022 - - US-based life sciences company Labcorp (NYSE: LH) has received Emergency Use Authorization from the US Food and Drug Administration for a combined at-home collection kit available that simultaneously detects COVID-19, influenza A...
Regencell Bioscience Posts Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19 in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period
19 May 2022 - - Hong Kong-based bioscience company Regencell Bioscience Holdings Ltd. (NASDAQ: RGC) has posted results from an analysis of a total of 51 individuals enrolled in its additional Evaluation and Assessment of RGC-COV19 ...
epocrates Launches Long COVID-19 Tool and Incorporates Late-Breaking Updates to an Expanding Library of Clinical Decision Support Guidelines
19 May 2022 - - US-based digital clinical decision support provider epocrates, an athenahealth, Inc. company, has recently made to its decision support tool content, all of which provides clinicians with the most current information and independent e...
Humanetics Expands Long-Haul COVID-19 Trial
19 May 2022 - - US-based clinical-stage pharmaceutical company Humanetics Corp has added two additional clinical sites to its long-haul COVID-19 study, which is focused on patients who were treated for severe COVID-19 and face the possible risk that ...
The Janssen Pharmaceutical Companies presents new TREMFYA(R) (guselkumab) data
19 May 2022 - The Janssen Pharmaceutical Companies of Johnson & Johnson announced on Wednesday the first results of the in vitro MODIF-Y studies, supporting a hypothesis that may differentiate the mechanism of first-in-class TREMFYA(R) (guselkuma...